evolcSign inStart free
Menu

Open call for tenders

MEDICAMENTE ANTINEOPLAZICE SI IMUNOMODULATOARE

Antineoplastic and immunomodulating agents · for SPITALUL MUNICIPAL PLOIESTI · Romania · published in Romanian

What the buyer wants

ACORD CADRU MEDICAMENTE ANTINEOPLAZICE SI IMUNOMODULATOARE conform caietului de sarcini

30 lots

  1. ACID IBANDRONIC 6 mg CONC. PT. SOL. PERF.
  2. ACIDUM ZOLEDRONICUM CONC. PT. SOL. PERF.
  3. ACIDUM ZOLEDRONICUM SOL. PERF.
  4. AVELUMABUM CONC. PT. SOL. PERF.
  5. BENDAMUSTINUM FLAC. 10ML CU PULB. PT. CONC. PT. SOL. PERF.
  6. BENDAMUSTINUM FLAC. 50 ML CU PULB. PT. CONC. PT. SOL. PERF.
  7. BEVACIZUMABUM FLACON X 4ML
  8. BEVACIZUMABUM FLACON X 16ML
  9. BLEOMYCINUM SULFAS PULB. PT. SOL. INJ./PERF
  10. BRENTUXIMAB VEDOTIN PULB. PT. CONC. PT. SOL. PERF.
  11. CABAZITAXELUM FLAC. A 4,5 ML CONC. PT. SOL. PERF.
  12. CABAZITAXELUM FLAC. CU 6 ML CONC. PT. SOL. PERF.
  13. CALCII FOLINAS FLACOANE CARE CONTIN 10 ML SOL. INJ./PERF.
  14. CALCII FOLINAS FLACOANE CARE CONTIN 35 ML SOL. INJ./PERF.
  15. CARBOPLATINUM FLAC. X 15 ML CONC. PT. SOL. PERF. X 150 MG CARBOPLATINA
  16. CARBOPLATINUM 1 FLAC. X 45 ML CONC. PT. SOL. PERF. X 450 MG CARBOPLATINA
  17. CARBOPLATINUM 1 FLAC. X 60 ML CONC. PT. SOL. PERF. X 600 MG CARBOPLATINA
  18. CARFILZOMIBUM 60 mg
  19. CEMIPLIMABUM 350 mg
  20. CETUXIMABUM 5mg/ml FLAC. X 20 ML SOL. PERF.
  21. CHLORAMBUCILUM 2 mg
  22. CISPLATINUM FLAC. CARE CONTINE 10 ML CONC. PT. SOL. PERF.
  23. CISPLATINUM 1 FLAC. CARE CONTINE 25 ML CONC. PT. SOL. PERF.
  24. CISPLATINUM 1 FLAC. DIN STICLA BRUNA CARE CONTINE 50 ML CONC. PT. SOL. PERF.
  25. CISPLATINUM 1 FLAC. DIN STICLA BRUNA CARE CONTINE 100 ML CONC. PT. SOL. PERF.
  26. CYCLOPHOSPHAMIDUM 200 mg
  27. CYTARABINUM 1 FLAC. DE 10 ML, X 10 ML SOL. INJ./PERF.
  28. CYTARABINUM 1 FLAC. CU CAPACITATEA DE 20 ML X 20 ML SOL. INJ./PERF.
  29. DACARBAZINUM 200 mg
  30. DACTINOMICINUM PULB. PT SOL INJ.

Companies that won similar tenders

Companies that won public tenders in the same category (Antineoplastic and immunomodulating agents) since 2024, according to EU award notices. Likely competitors, or partners for a joint offer.